“1. first bionic hand with a sense of touch that can be worn outside a laboratory
2. development of a new 3D bioprinting technique, which allows the more accurate printing of soft tissue organs, such as lungs
3. a method through which the human innate immune system may possibly be trained to more efficiently respond to diseases and infections
4. a new form of biomaterial based delivery system for therapeutic drugs, which only release their cargo under certain physiological conditions, thereby potentially reducing drug side-effects in patients
5. an announcement of human clinical trials, that will encompass the use of CRISPR technology to modify the T cells of patients with multiple myeloma, sarcoma and melanoma cancers, to allow the cells to more effectively combat the cancers, the first of their kind trials in the US
6. a blood test (or liquid biopsy) that can detect eight common cancer tumors early. The new test, based on cancer-related DNA and proteins found in the blood, produced 70% positive results in the tumor-types studied in 1005 patients
7. a method of turning skin cells into stem cells, with the use of CRISPR
the creation of two monkey clones for the first time
8. a paper which presents possible evidence that naked mole-rats do not face increased mortality risk due to aging”
That is an excerpt from an excerpt, but I found the list astonishing. These are advancements from only the field of biology, only from 2018… and as the article goes on to say, onlyfrom January 2018. Remarkable. I know very little of how life sciences work, but the article was very informative on that score.
Do Uber and Lyft contribute to congestion? Note the funding agencies.
“But perhaps he also sensed that power in society is shifting from the institutions he oversaw, to those that distribute private capital—it wouldn’t be the wrong read, even if it’s an unsettling one.”
.. A not altogether pretty look at the VC industry and its evolution over time.